| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |